Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 7:12 pm Sale |
2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Jackson Square Partners LLC | 15,005,177 6.640% |
-7,418,738 (-33.08%) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 20,279,035 8.970% |
424,159 (+2.14%) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
BlackRock Inc. BLK |
18,534,459 8.200% |
1,965,215 (+11.86%) |
Filing History |
| 2023-02-03 06:10 am Purchase |
2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Sumitomo Mitsui Trust Group, Inc. | 14,166,193 6.260% |
2,251,168 (+18.89%) |
Filing History |
| 2022-06-01 4:00 pm Purchase |
2022-03-15 | 13G | Pacific Biosciences of California, Inc. PACB |
MADRONE CAPITAL PARTNERS LLC | 16,915,933 7.500% |
16,915,933 (New Position) |
Filing History |
| 2022-02-14 06:05 am Purchase |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Nikko Asset Management Americas, Inc. | 11,915,025 5.400% |
11,915,025 (New Position) |
Filing History |
| 2022-02-11 11:20 am Purchase |
2022-02-14 | 13G | Pacific Biosciences of California, Inc. PACB |
Capital International Investors | 12,106,318 5.500% |
2,298,292 (+23.43%) |
Filing History |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 19,854,876 9.000% |
5,534,577 (+38.65%) |
Filing History |
| 2022-02-09 2:45 pm Sale |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 26,383,103 11.960% |
-2,121,526 (-7.44%) |
Filing History |
| 2022-02-04 8:55 pm Purchase |
2022-01-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Jackson Square Partners LLC | 22,423,915 10.170% |
8,949,477 (+66.42%) |
Filing History |
| 2022-02-04 06:09 am Purchase |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Sumitomo Mitsui Trust Group, Inc. | 11,915,025 5.400% |
11,915,025 (New Position) |
Filing History |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
BlackRock Inc. BLK |
16,569,244 7.500% |
1,453,754 (+9.62%) |
Filing History |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 28,504,629 15.320% |
8,659,849 (+43.64%) |
Filing History |
| 2021-02-16 4:04 pm Purchase |
2021-02-16 | 13G | Pacific Biosciences of California, Inc. PACB |
Capital International Investors | 9,808,026 5.300% |
9,808,026 (New Position) |
Filing History |
| 2021-02-10 11:40 am Purchase |
2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 14,320,299 7.700% |
6,443,814 (+81.81%) |
Filing History |
| 2021-02-09 2:10 pm Purchase |
2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
Jackson Square Partners LLC | 13,474,438 7.240% |
13,474,438 (New Position) |
Filing History |
| 2021-01-29 5:22 pm Purchase |
2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
BlackRock Inc. BLK |
15,115,490 8.100% |
3,082,170 (+25.61%) |
Filing History |
| 2020-10-09 2:00 pm Purchase |
2020-09-30 | 13G | Pacific Biosciences of California, Inc. PACB |
ARK Investment Management LLC | 19,844,780 11.230% |
19,844,780 (New Position) |
Filing History |